BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) saw a significant decline in short interest in July. As of July 15th, there was short interest totaling 4,285 shares, a decline of 47.3% from the June 30th total of 8,126 shares. Based on an average daily volume of 2,510 shares, the days-to-cover ratio is currently 1.7 days.
BioSyent Trading Up 0.5%
BIOYF stock opened at $10.44 on Wednesday. BioSyent has a 1-year low of $7.63 and a 1-year high of $12.00. The business’s 50 day moving average is $10.14 and its 200-day moving average is $10.40.
BioSyent Company Profile
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
See Also
- Five stocks we like better than BioSyent
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
